Silence Therapeutics (SLN) Goodwill (2018 - 2026)
Silence Therapeutics recorded quarterly Goodwill of $10.4 million in Q1 2026, down 2.48% quarter-over-quarter from $10.6 million in Q4 2025, and down 2.48% year-over-year from $10.6 million in Q1 2025.
Silence Therapeutics' Goodwill history runs 9 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- In Q1 2026, Goodwill fell 2.48% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 2.48% YoY), while the FY2025 annual figure was $10.6 million, up 13.09% from the prior year.
- Goodwill came in at $10.4 million for Q1 2026 at Silence Therapeutics, down from $10.6 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $10.6 million in Q1 2025 to a low of $9.4 million in Q3 2022.
- A 5-year average of $9.9 million and a median of $9.8 million in 2024 frame the typical range for Goodwill.
- Across the five-year window, Goodwill dropped 12.62% in 2022 and increased 13.09% in 2025, its largest moves.
- Silence Therapeutics' Goodwill stood at $9.4 million in 2022, then rose by 3.58% to $9.7 million in 2023, then retreated by 3.48% to $9.4 million in 2024, then gained by 13.09% to $10.6 million in 2025, then declined by 2.48% to $10.4 million in 2026.
- According to Business Quant data, Goodwill over the past three periods registered $10.4 million, $10.6 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.36 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Sep 30, 2025 | 10.61 Mn |
| Jun 30, 2025 | 10.62 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 9.39 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Mar 31, 2024 | 9.76 Mn |
| Dec 31, 2023 | 9.73 Mn |
| Sep 30, 2023 | 9.92 Mn |
| Jun 30, 2023 | 9.73 Mn |
| Mar 31, 2023 | 9.68 Mn |
| Dec 31, 2022 | 9.39 Mn |
| Sep 30, 2022 | 9.38 Mn |
| Jun 30, 2022 | 9.80 Mn |
| Mar 31, 2022 | 10.27 Mn |
| Dec 31, 2021 | 10.23 Mn |
| Sep 30, 2021 | 10.73 Mn |
| Jun 30, 2021 | 10.85 Mn |
| Dec 31, 2020 | 10.73 Mn |
| Jun 30, 2020 | 10.23 Mn |
| Dec 31, 2019 | 9.89 Mn |
| Jun 30, 2019 | 10.42 Mn |
| Dec 31, 2018 | 10.46 Mn |